Filippo Pigazzani

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Venues

Health technology assessment (Winchester, England)

Antioxidants (Basel, Switzerland)

Scientific reports

BMJ open

University of Dundee

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Dundee May 01 2017

United Kingdom

Clinical Research Fellow :: Molecular Medicine

Azienda Ospedaliero Universitaria di Parma Apr 01 2012 - Apr 30 2017

Italy

Cardiologist :: Cardiology

Publications

Isla S Mackenzie, Christopher J Hawkey, Ian Ford, Nicola Greenlaw, Filippo Pigazzani, Amy Rogers, Allan D Struthers, Alan G Begg, Li Wei, Anthony J Avery, Jaspal S Taggar, Andrew Walker, Suzanne L Duce, Rebecca J Barr, Jennifer S Dumbleton, Evelien D Rooke, Jonathan N Townend, Lewis D Ritchie, Thomas M MacDonald, null null
Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation. Health technology assessment (Winchester, England) 28 (18) (2024)
Isla S Mackenzie, Christopher J Hawkey, Ian Ford, Nicola Greenlaw, Filippo Pigazzani, Amy Rogers, Allan D Struthers, Alan G Begg, Li Wei, Anthony J Avery, Jaspal S Taggar, Andrew Walker, Suzanne L Duce, Rebecca J Barr, Jennifer S Dumbleton, Evelien D Rooke, Jonathan N Townend, Lewis D Ritchie, Thomas M MacDonald, null null
Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation. Health technology assessment (Winchester, England) 28 (18) (2024)
Isla S Mackenzie, Christopher J Hawkey, Ian Ford, Nicola Greenlaw, Filippo Pigazzani, Amy Rogers, Allan D Struthers, Alan G Begg, Li Wei, Anthony J Avery, Jaspal S Taggar, Andrew Walker, Suzanne L Duce, Rebecca J Barr, Jennifer S Dumbleton, Evelien D Rooke, Jonathan N Townend, Lewis D Ritchie, Thomas M MacDonald, null null
Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation. Health technology assessment (Winchester, England) 28 (18) (2024)
Filippo Pigazzani, Davide Gorni, Kenneth A Dyar, Matteo Pedrelli, Gwen Kennedy, Gabriele Costantino, Agostino Bruno, Isla Mackenzie, Thomas M MacDonald, Uwe J F Tietge, Jacob George
The Prognostic Value of Derivatives-Reactive Oxygen Metabolites (d-ROMs) for Cardiovascular Disease Events and Mortality: A Review. Antioxidants (Basel, Switzerland) 11 (8) (2022)
Amy Rogers, Evelien D Rooke, Steve V Morant, Greg Guthrie, Alexander S F Doney, Andrew Duncan, Isla S Mackenzie, Rebecca J Barr, Filippo Pigazzani, Krists Zutis, Thomas M MacDonald
Adverse events and overall health and well-being after COVID-19 vaccination: interim results from the VAC4COVID cohort safety study. BMJ open 12 (6) (2022)
Giuliana Gobbi, Cecilia Carubbi, Guidantonio Malagoli Tagliazucchi, Elena Masselli, Prisco Mirandola, Filippo Pigazzani, Antonio Crocamo, Maria Francesca Notarangelo, Sergio Suma, Elvezia Paraboschi, Giuseppe Maglietta, Srikanth Nagalla, Giulia Pozzi, Daniela Galli, Mauro Vaccarezza, Paolo M Fortina, Sankar Addya, Adam Ertel, Paul Bray, Stefano Duga, Carlo Berzuini, Marco Vitale, Diego Ardissino
Sighting acute myocardial infarction through platelet gene expression. Scientific reports 9 (1) (2019)
Filippo Pigazzani, Isla Mackenzie, Thomas M MacDonald
Ibuprofen and Paracetamol: Acceptably Safe for All? Drug safety 41 (11) (2018)

Filippo Pigazzani.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Filippo Pigazzani